Bio-Rad, Harvard Bio Lead Declines in BCW Index | GenomeWeb

Bio-Rad Laboratories and Harvard Bioscience had the sharpest declines in stock price among the multi-platform molecular biology tool firms that comprise the BCW Index. Of the 15 companies tracked by BioCommerce Week, 13 ended the weekly tracking period down — the exceptions being Applied Biosystems and Stratagene.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.